Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL002525

Drug Information
NameMGCD265
CompanyMethylGene Montreal, Canada
IndicationNSCLC (combination therapy)
[ICD9: 162   ICD10: C33, C34]
Phase I/II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C26H20FN5O2S2/c1-32-14-20(29-15-32)23-13-19-25(36-23)22(9-10-2
8-19)34-21-8-7-17(12-18(21)27)30-26(35)31-24(33)11-16-5-3-2-4-6-1
6/h2-10,12-15H,11H2,1H3,(H2,30,31,33,35)
InChIKeyUFICVEHDQUKCEA-UHFFFAOYSA-N
Canonical SMILESCN1C=C(N=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=S)NC(=O)CC5=CC=CC=C5)F    
FormulaC26H20FN5O2S2
PubChem Compound IDCID 24901704.
TargetMultiple kinase



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543